# Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction

> **NCT00979758** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 100 (actual)

## Conditions studied

- Myocardial Infarction
- Stem Cell Transplantation
- Angioplasty, Transluminal, Percutaneous Coronary

## Interventions

- **DRUG:** Atorvastatin and mononuclear cells transplantation

## Key facts

- **NCT ID:** NCT00979758
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2015-06
- **Final completion:** 2016-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979758, "Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00979758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*